Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuromyelitis Optica | 26 | 2024 | 258 | 4.400 |
Why?
|
| Aquaporin 4 | 24 | 2024 | 151 | 2.600 |
Why?
|
| Autoantibodies | 24 | 2024 | 2068 | 1.180 |
Why?
|
| Optic Neuritis | 6 | 2023 | 168 | 0.920 |
Why?
|
| Natural Killer T-Cells | 1 | 2022 | 314 | 0.690 |
Why?
|
| Multiple Sclerosis | 9 | 2023 | 3118 | 0.510 |
Why?
|
| Myelin P0 Protein | 1 | 2012 | 15 | 0.430 |
Why?
|
| Immunoglobulin G | 8 | 2024 | 4575 | 0.400 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2012 | 93 | 0.390 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 2 | 2020 | 33 | 0.370 |
Why?
|
| Complement System Proteins | 2 | 2024 | 803 | 0.360 |
Why?
|
| Spinal Cord | 6 | 2023 | 1809 | 0.330 |
Why?
|
| Astrocytes | 6 | 2021 | 1301 | 0.320 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2024 | 838 | 0.310 |
Why?
|
| Antibodies, Blocking | 2 | 2021 | 254 | 0.300 |
Why?
|
| Encephalitis | 2 | 2024 | 429 | 0.290 |
Why?
|
| Paraparesis | 2 | 2017 | 14 | 0.240 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 3 | 2020 | 528 | 0.230 |
Why?
|
| Hashimoto Disease | 1 | 2024 | 101 | 0.220 |
Why?
|
| Polyesters | 1 | 2024 | 366 | 0.210 |
Why?
|
| Myelin Sheath | 2 | 2016 | 653 | 0.210 |
Why?
|
| Receptors, Complement | 1 | 2022 | 262 | 0.210 |
Why?
|
| Antigen-Antibody Complex | 1 | 2024 | 530 | 0.200 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2022 | 72 | 0.200 |
Why?
|
| Pandemics | 1 | 2022 | 8607 | 0.200 |
Why?
|
| Tremor | 2 | 2013 | 184 | 0.200 |
Why?
|
| Meningitis | 1 | 2022 | 214 | 0.180 |
Why?
|
| Aquaporins | 1 | 2021 | 172 | 0.180 |
Why?
|
| Methylprednisolone | 5 | 2017 | 389 | 0.180 |
Why?
|
| Complement Activation | 1 | 2021 | 452 | 0.170 |
Why?
|
| Receptors, IgG | 1 | 2022 | 583 | 0.170 |
Why?
|
| Sjogren's Syndrome | 1 | 2021 | 234 | 0.160 |
Why?
|
| Neuroprotective Agents | 2 | 2023 | 952 | 0.160 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 2017 | 17 | 0.160 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2020 | 236 | 0.150 |
Why?
|
| Interleukin-17 | 1 | 2024 | 908 | 0.150 |
Why?
|
| Cytokines | 3 | 2024 | 7400 | 0.150 |
Why?
|
| Heavy Metal Poisoning, Nervous System | 1 | 2016 | 5 | 0.150 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 1 | 2016 | 17 | 0.150 |
Why?
|
| Rodenticides | 1 | 2016 | 21 | 0.140 |
Why?
|
| Thallium | 1 | 2016 | 101 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 1843 | 0.140 |
Why?
|
| Japan | 4 | 2020 | 1377 | 0.140 |
Why?
|
| Medulla Oblongata | 1 | 2016 | 242 | 0.130 |
Why?
|
| Prednisolone | 4 | 2021 | 333 | 0.120 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2016 | 124 | 0.120 |
Why?
|
| Seasons | 1 | 2020 | 1511 | 0.120 |
Why?
|
| Retina | 2 | 2016 | 2636 | 0.120 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2017 | 355 | 0.120 |
Why?
|
| Bulbo-Spinal Atrophy, X-Linked | 1 | 2013 | 4 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3198 | 0.120 |
Why?
|
| Earthquakes | 1 | 2016 | 179 | 0.120 |
Why?
|
| Propylene Glycols | 1 | 2014 | 90 | 0.120 |
Why?
|
| Recurrence | 6 | 2023 | 8422 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2022 | 2161 | 0.110 |
Why?
|
| Humans | 48 | 2024 | 752741 | 0.110 |
Why?
|
| Research | 1 | 2022 | 2001 | 0.110 |
Why?
|
| Optic Nerve Diseases | 1 | 2016 | 333 | 0.110 |
Why?
|
| Mutation | 3 | 2017 | 29981 | 0.110 |
Why?
|
| Tacrolimus | 1 | 2016 | 725 | 0.110 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 1 | 2012 | 17 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 836 | 0.100 |
Why?
|
| Immunosuppressive Agents | 2 | 2016 | 4121 | 0.100 |
Why?
|
| Encephalomyelitis | 1 | 2012 | 35 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2022 | 35798 | 0.100 |
Why?
|
| Demyelinating Diseases | 1 | 2014 | 355 | 0.100 |
Why?
|
| Sphingosine | 1 | 2014 | 305 | 0.100 |
Why?
|
| Disease Progression | 3 | 2020 | 13364 | 0.100 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 1101 | 0.100 |
Why?
|
| Multienzyme Complexes | 1 | 2014 | 669 | 0.090 |
Why?
|
| Neuroglia | 1 | 2016 | 944 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2016 | 690 | 0.090 |
Why?
|
| Frontal Lobe | 1 | 2017 | 1398 | 0.090 |
Why?
|
| Disulfides | 1 | 2012 | 456 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2012 | 596 | 0.090 |
Why?
|
| Disasters | 1 | 2016 | 518 | 0.090 |
Why?
|
| Brain | 6 | 2021 | 26598 | 0.090 |
Why?
|
| Muscular Diseases | 1 | 2014 | 552 | 0.090 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2012 | 235 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2023 | 2822 | 0.090 |
Why?
|
| Blood-Brain Barrier | 2 | 2021 | 1017 | 0.080 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2016 | 533 | 0.080 |
Why?
|
| Postural Balance | 1 | 2013 | 621 | 0.080 |
Why?
|
| Male | 29 | 2022 | 354311 | 0.080 |
Why?
|
| Plasmapheresis | 1 | 2009 | 203 | 0.080 |
Why?
|
| Leukocyte Count | 2 | 2023 | 1604 | 0.080 |
Why?
|
| Leg | 1 | 2013 | 1123 | 0.080 |
Why?
|
| Action Potentials | 2 | 2013 | 1807 | 0.080 |
Why?
|
| Adult | 22 | 2022 | 216658 | 0.080 |
Why?
|
| Sensory Receptor Cells | 1 | 2012 | 498 | 0.070 |
Why?
|
| Th17 Cells | 1 | 2014 | 771 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2012 | 549 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2016 | 1558 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 1068 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1186 | 0.070 |
Why?
|
| Autoantigens | 2 | 2020 | 901 | 0.070 |
Why?
|
| Middle Aged | 19 | 2022 | 216054 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 4062 | 0.070 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 1431 | 0.070 |
Why?
|
| Head | 1 | 2011 | 898 | 0.060 |
Why?
|
| Antigens | 1 | 2010 | 1466 | 0.060 |
Why?
|
| Glycols | 1 | 2024 | 58 | 0.060 |
Why?
|
| Female | 22 | 2022 | 385090 | 0.060 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2023 | 76 | 0.060 |
Why?
|
| Young Adult | 9 | 2021 | 57267 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 3069 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2010 | 1374 | 0.050 |
Why?
|
| Age of Onset | 1 | 2009 | 3290 | 0.050 |
Why?
|
| Pulse Therapy, Drug | 2 | 2012 | 35 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2016 | 4316 | 0.050 |
Why?
|
| Oligoclonal Bands | 1 | 2020 | 16 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 3034 | 0.040 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2022 | 289 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2021 | 352 | 0.040 |
Why?
|
| Optic Nerve | 1 | 2023 | 558 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2023 | 516 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2021 | 1089 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2022 | 4228 | 0.040 |
Why?
|
| Aged | 9 | 2021 | 165629 | 0.040 |
Why?
|
| Albumins | 1 | 2021 | 564 | 0.040 |
Why?
|
| Immunity | 1 | 2023 | 1007 | 0.040 |
Why?
|
| Atrophy | 1 | 2022 | 1600 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2021 | 64017 | 0.040 |
Why?
|
| Dopamine | 1 | 2023 | 1584 | 0.030 |
Why?
|
| Sirolimus | 1 | 2024 | 1568 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9300 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 2223 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 22009 | 0.030 |
Why?
|
| Adolescent | 6 | 2021 | 86713 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2023 | 78758 | 0.030 |
Why?
|
| Biopsy | 2 | 2017 | 6771 | 0.030 |
Why?
|
| Myelitis, Transverse | 1 | 2014 | 41 | 0.030 |
Why?
|
| Phenotype | 1 | 2012 | 16484 | 0.030 |
Why?
|
| Podocytes | 1 | 2017 | 406 | 0.030 |
Why?
|
| Aquaporin 1 | 1 | 2013 | 58 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2020 | 1842 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5974 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 628 | 0.030 |
Why?
|
| Animals | 6 | 2024 | 169600 | 0.030 |
Why?
|
| Alopecia | 1 | 2016 | 392 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2013 | 445 | 0.030 |
Why?
|
| Rats | 2 | 2023 | 24248 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 39223 | 0.020 |
Why?
|
| Orbit | 1 | 2015 | 439 | 0.020 |
Why?
|
| Housing | 1 | 2016 | 673 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2016 | 560 | 0.020 |
Why?
|
| Xenopus | 1 | 2013 | 714 | 0.020 |
Why?
|
| Clonazepam | 1 | 2011 | 136 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 4929 | 0.020 |
Why?
|
| Eye | 1 | 2015 | 731 | 0.020 |
Why?
|
| Child | 4 | 2021 | 78594 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 1410 | 0.020 |
Why?
|
| Siblings | 1 | 2014 | 850 | 0.020 |
Why?
|
| Cricetinae | 1 | 2013 | 2471 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 4637 | 0.020 |
Why?
|
| Oocytes | 1 | 2013 | 1193 | 0.020 |
Why?
|
| Cell Separation | 1 | 2014 | 1751 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2017 | 2129 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 40195 | 0.020 |
Why?
|
| Mice | 2 | 2024 | 81766 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9223 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2016 | 2603 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3837 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2748 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3885 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 40939 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 25454 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2776 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 969 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 18174 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2015 | 2950 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 2499 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2014 | 2526 | 0.010 |
Why?
|
| Acute Disease | 1 | 2014 | 7221 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 6624 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10751 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2016 | 6458 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 9990 | 0.010 |
Why?
|
| Kidney | 1 | 2017 | 7152 | 0.010 |
Why?
|
| Blindness | 1 | 2006 | 588 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13778 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 4185 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2011 | 1921 | 0.010 |
Why?
|
| Protein Binding | 1 | 2013 | 9408 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 13984 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21904 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 18050 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 41390 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29264 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 58361 | 0.000 |
Why?
|
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_